Related Experiment Video
Updated: Aug 2, 2025

06:50
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
1.9K
A web server for predicting and scanning of IL-5 inducing peptides using alignment-free and alignment-based method.
Leimarembi Devi Naorem1, Neelam Sharma1, Gajendra P S Raghava1
1Department of Computational Biology, Indraprastha Institute of Information Technology, Okhla Phase 3, New Delhi, 110020, India.
Computers in Biology and Medicine
|April 14, 2023
Summary
This study developed a hybrid computational model to accurately predict Interleukin-5 (IL-5) inducing regions in proteins, aiding research into eosinophil-mediated diseases. The IL5pred tool offers a user-friendly interface for this prediction.
Area of Science:
- Immunology
- Computational Biology
- Bioinformatics
Background:
- Interleukin-5 (IL-5) is a key therapeutic target for eosinophil-mediated diseases.
- Predicting IL-5 inducing antigenic regions is crucial for therapeutic development.
Purpose of the Study:
- To develop a highly precise computational model for predicting IL-5 inducing antigenic regions in proteins.
- To create a user-friendly tool for researchers to identify potential IL-5 epitopes.
Main Methods:
- Utilized experimentally validated peptide data from IEDB for training and testing.
- Developed and compared alignment-based, alignment-free (machine learning), and hybrid models.
- Evaluated models using Area Under the Curve (AUC) and Matthews Correlation Coefficient (MCC).
Main Results:
- Alignment-free models, particularly a dipeptide-based Random Forest, showed improved performance (AUC 0.75).
- A hybrid model combining alignment-based and alignment-free methods achieved the highest performance (AUC 0.94, MCC 0.60).
- Identified specific residues (Ile, Asn, Tyr) enriched in IL-5 inducing peptides.
Conclusions:
- The developed hybrid model significantly enhances the prediction of IL-5 inducing regions.
- The 'IL5pred' web server and standalone package provide a valuable resource for immunologists and drug developers.
- This work facilitates the design of targeted therapies for IL-5 driven diseases.

